A novel technique for modeling susceptibility-based contrast mechanisms for arbitrary microvascular geometries: The finite perturber method
暂无分享,去创建一个
B. Douglas Ward | Kathleen M. Schmainda | Arvind P. Pathak | A. Pathak | K. Schmainda | B. D. Ward | B. Ward | B. D. Ward | Arvind P. Pathak
[1] Yu-Chung N. Cheng,et al. Magnetic Resonance Imaging: Physical Principles and Sequence Design , 1999 .
[2] P. Lantos,et al. The vasculature of experimental brain tumours Part 2. A quantitative assessment of morphological abnormalities , 1981, Journal of the Neurological Sciences.
[3] J. Gore,et al. Intravascular susceptibility contrast mechanisms in tissues , 1994, Magnetic resonance in medicine.
[4] B. Rosen,et al. Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.
[5] B. Rosen,et al. Microscopic susceptibility variation and transverse relaxation: Theory and experiment , 1994, Magnetic resonance in medicine.
[6] B. Rosen,et al. Susceptibility contrast imaging of cerebral blood volume: Human experience , 1991, Magnetic resonance in medicine.
[7] V. Kiselev. Transverse relaxation effect of MRI contrast agents: A crucial issue for quantitative measurements of cerebral perfusion , 2005, Journal of magnetic resonance imaging : JMRI.
[8] B. Rosen,et al. Functional mapping of the human visual cortex by magnetic resonance imaging. , 1991, Science.
[9] Mark Jenkinson,et al. Perturbation method for magnetic field calculations of nonconductive objects , 2004, Magnetic resonance in medicine.
[10] A S Greene,et al. Imaging system for three-dimensional mapping of cerebrocortical capillary networks in vivo. , 1993, Microvascular research.
[11] E F Halpern,et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.
[12] K. Zierler. Theoretical Basis of Indicator‐Dilution Methods For Measuring Flow and Volume , 1962 .
[13] V G Kiselev. On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI , 2001, Magnetic resonance in medicine.
[14] John S Leigh,et al. Quantifying arbitrary magnetic susceptibility distributions with MR , 2004, Magnetic resonance in medicine.
[15] E. Haacke,et al. Theory of NMR signal behavior in magnetically inhomogeneous tissues: The static dephasing regime , 1994, Magnetic resonance in medicine.
[16] E. M. Lifshitz,et al. Electrodynamics of continuous media , 1961 .
[17] Bruce R. Rosen,et al. MR Diffusion Imaging of the Human Brain , 1990, Journal of computer assisted tomography.
[18] Xenophon Papademetris,et al. Rapid calculations of susceptibility-induced magnetostatic field perturbations for in vivo magnetic resonance , 2006, Physics in medicine and biology.
[19] S. Ogawa,et al. Magnetic resonance imaging of blood vessels at high fields: In vivo and in vitro measurements and image simulation , 1990, Magnetic resonance in medicine.
[20] Mark S. Cohen,et al. Contrast agents and cerebral hemodynamics , 1991, Magnetic resonance in medicine.
[21] A P Pathak,et al. Utility of simultaneously acquired gradient‐echo and spin‐echo cerebral blood volume and morphology maps in brain tumor patients , 2000, Magnetic resonance in medicine.
[22] K. J. Binns,et al. Analysis and computation of electric and magnetic field problems , 1973 .
[23] R. Weisskoff,et al. MRI susceptometry: Image‐based measurement of absolute susceptibility of MR contrast agents and human blood , 1992, Magnetic resonance in medicine.
[24] Samuel Fox,et al. 41st ANNUAL MEETING , 1964 .
[25] B R Rosen,et al. Mr contrast due to intravascular magnetic susceptibility perturbations , 1995, Magnetic resonance in medicine.
[26] A P Pathak,et al. MR‐derived cerebral blood volume maps: Issues regarding histological validation and assessment of tumor angiogenesis , 2001, Magnetic resonance in medicine.
[27] J. R. Baker,et al. The intravascular contribution to fmri signal change: monte carlo modeling and diffusion‐weighted studies in vivo , 1995, Magnetic resonance in medicine.
[28] B. Rosen,et al. MR Contrast Due to Microscopically Heterogeneous Magnetic Susceptibility: Numerical Simulations and Applications to Cerebral Physiology , 1991, Magnetic resonance in medicine.
[29] R Weissleder,et al. Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties , 1993, Magnetic resonance in medicine.
[30] T Kubota,et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. , 1993, Radiology.
[31] Scott D Rand,et al. The effect of brain tumor angiogenesis on the in vivo relationship between the gradient‐echo relaxation rate change (ΔR2*) and contrast agent (MION) dose , 2003, Journal of magnetic resonance imaging : JMRI.
[32] Peter A. Bandettini,et al. Effects of biophysical and physiologic parameters on brain activation‐induced R2* and R2 changes: Simulations using a deterministic diffusion model , 1995, Int. J. Imaging Syst. Technol..